Syndesi Therapeutics

Syndesi Therapeutics

Syndesi Therapeutics

Syndesi Therapeutics is developing molecules that uniquely modulate the synaptic vesicle protein SV2A, which plays a central role in synaptic transmission (the communication between neurons in the brain).
Type
B2c
Founded
2018
Raised
$21M
Follow us
Alexa global traffic share